`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
` v.
`
`
`
`SANOFI-AVENTIS DEUTSCHLAND GMBH,
`Patent Owner.
`
`
`
`
`Case IPR2018-01675
`Patent Number: 8,603,044
`
`
`
`
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`Patent Owner, Sanofi-Aventis Deutschland GmbH, hereby submits its
`
`mandatory notices pursuant to 37 C.F.R. § 42.8(a)(3).
`
`
`
`A. Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)) - Unchanged
`
`The real parties-in-interest are the following: Sanofi-Aventis Deutschland
`
`GmbH (patent owner of U.S. Patent No. 8,603,044 (“the ’044 Patent”)), Sanofi-
`
`Aventis U.S. LLC (exclusive licensee of the ’044 Patent), and Sanofi Winthrop
`
`Industrie (exclusive licensee of the ’044 Patent). Evidence supporting Sanofi-
`
`Aventis Deutschland GmbH’s status as the patent owner is found on the face of the
`
`’044 Patent.
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2)) - Unchanged
`
`The following judicial and/or administrative proceedings could affect, or be
`
`affected by, a decision in this proceeding:
`
`- Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, Sanofi
`Winthrop Industrie v. Mylan GmbH, Biocon Ltd., Biocon Research Ltd.,
`Biocon Sdn. Bhd. and Biocon S.A., Case No. 2-17-cv-09105-SRC-CLW,
`U.S. District Court for New Jersey;
`
`- Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH, and Sanofi
`Winthrop Industrie v. Merck Sharp & Dohme Corp., Case No. 1-16-cv-
`00812-RGA-MPT, U.S. District Court for the District of Delaware;
`
`- Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GmbH v. Eli Lilly
`and Company, Case No. 1-14-cv-00113-RGA-MPT, U.S. District Court
`for the District of Delaware;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01670, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No. 8,679,069;
`
`
`
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01676, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No. 8,603,044;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01678, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office; involving U.S. Patent No.8,992,486;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01679, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No.8,992,486;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01680, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No. 9,526,844;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01682, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No. 9,526,844;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2018-01684, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No. 9,604,008;
`
`- Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH,
`IPR2019-00122, Patent Trial and Appeal Board, U.S. Patent and
`Trademark Office, involving U.S. Patent No.8,992,486;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00977, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No. 8,603,044;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00978, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No. 8,603,044;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00979, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No. 8,679,069;
`
`
`
`3
`
`
`
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00980, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office; involving
`U.S. Patent No.8,992,486;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00981, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office; involving
`U.S. Patent No.8,992,486;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00982, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No.8,992,486;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-00987, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No. 9,604,008;
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-01022, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No. 9,526,844; and
`
`- Pfizer Inc. v. Sanofi-Aventis Deutschland GmbH, IPR2019-01023, Patent
`Trial and Appeal Board, U.S. Patent and Trademark Office, involving
`U.S. Patent No. 9,526,844.
`
`The ’044 Patent, U.S. Application No. 13/909,649, is a continuation of U.S.
`
`Patent Application No. 12/944,544, now U.S. Patent No. 8,679,069, which is a
`
`continuation of U.S. Patent Application No. 11/483,546, now U.S. Patent No.
`
`7,918,833, which is a continuation of U.S. Patent Application No. 10/790,225, now
`
`abandoned, and claims priority to GB Patent Application No. 0304822.
`
`No U.S. patents or U.S. patent applications claim priority to the ’044 Patent.
`
`
`
`The following additional U.S. patents and U.S. patent applications claim
`
`priority to one or more of the same application(s) to which the ’044 Patent claims
`
`
`
`4
`
`
`
`priority:
`
`• U.S. Patent Application No. 10/790,866
`
`• U.S. Patent Application No. 15/681,604
`
`• U.S. Patent Application No. 15/787,737
`
`• U.S. Patent Application No. 16/385,682
`
`• U.S. Patent Application No. 12/320,189, now U.S. Pat. No. 7,850,662
`
`• U.S. Patent Application No. 11/520,598, now U.S. Pat. No. 7,935,088
`
`• U.S. Patent Application No. 13/040,198, now U.S. Pat. No. 8,512,297
`
`• U.S. Patent Application No. 13/075,212, now U.S. Pat. No. 8,556,864
`
`• U.S. Patent Application No. 13/909,681, now U.S. Pat. No. 8,992,486
`
`• U.S. Patent Application No. 13/919,251, now U.S. Pat. No. 9,011,391
`
`• U.S. Patent Application No. 12/941,702, now U.S. Pat. No. 9,028,454
`
`• U.S. Patent Application No. 12/357,899, now U.S. Pat. No. 9,205,197
`
`• U.S. Patent Application No. 14/635,573, now U.S. Pat. No. 9,233,211
`
`• U.S. Patent Application No. 14/946,203, now U.S. Pat. No. 9,408,979
`
`• U.S. Patent Application No. 15/156,616, now U.S. Pat. No. 9,526,844
`
`• U.S. Patent Application No. 14/319,379, now U.S. Pat. No. 9,533,105
`
`• U.S. Patent Application No. 14/319,384, now U.S. Pat. No. 9,561,331
`
`• U.S. Patent Application No. 14/319,388, now U.S. Pat. No. 9,604,008
`
`• U.S. Patent Application No. 14/319,394, now U.S. Pat. No. 9,604,009
`
`
`
`5
`
`
`
`
`
`LEAD COUNSEL
`Elizabeth Stotland Weiswasser
`Reg. No. 55,721
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`elizabeth.weiswasser@weil.com
`Phone: 212-310-8022
`Fax: 212-310-8007
`
`
`
`• U.S. Patent Application No. 14/319,381, now U.S. Pat. No. 9,610,409
`
`• U.S. Patent Application No. 14/319,371, now U.S. Pat. No. 9,623,189
`
`• U.S. Patent Application No. 15/180,148, now U.S. Pat. No. 9,623,190
`
`• U.S. Patent Application No. 15/180,141, now U.S. Pat. No. 9,775,954
`
`• U.S. Patent Application No. 14/319,377, now U.S. Pat. No. 9,827,379
`
`C. Lead and Back-Up Counsel and Service Information (37 C.F.R. §
`42.8(b)(3)-(4)) - Updated
`
`BACK-UP COUNSEL
`W. Karl Renner
`Reg. No. 41,265
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Phone: 202-783-5070
`Fax: 612-288-9696
`Email: PTABInbound@fr.com
`Anish R. Desai
`Reg. No. 73,760
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`anish.desai@weil.com
`Phone: 212-310-8730
`Fax: 212-310-8007
`Sudip K. Kundu
`Reg. No. 74,193
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`sudip.kundu@weil.com
`Phone: 212-310-8562
`Fax: 212-310-8007
`
`
`
`6
`
`
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`Kathryn M. Kantha
`Reg. No. 70,371
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`kathryn.kantha@weil.com
`Phone: 212-310-8621
`Fax: 212-310-8007
`Adrian C. Percer
`Reg. No. 46,986
`Weil, Gotshal & Manges LLP
`201 Redwood Shores Parkway
`Redwood Shores, CA 94065
`adrian.percer@weil.com
`Phone: 650-802-3124
`Fax: 650-802-3100
`Brian C. Chang
`Reg. No. 74,301
`Weil, Gotshal & Manges LLP
`201 Redwood Shores Parkway
`Redwood Shores, CA 94065
`brian.chang@weil.com
`Phone: 650-802-3936
`Fax: 650-802-3100
`William S. Ansley
`Reg. No. 67,828
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`sutton.ansley@weil.com
`Phone: 202-682-7018
`Fax: 202-857-0940
`
`
`
`7
`
`
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`Matthew D. Sieger
`Reg. No. 76,051
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`matthew.sieger@weil.com
`Phone: 202-682-7177
`Fax: 202-857-0940
`John S. Goetz
`Reg. No. 54,867
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Phone: 202-783-5070
`Fax: 612-288-9696
`Email: PTABInbound@fr.com
`Joshua A. Griswold
`Reg. No. 46,310
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Phone: 202-783-5070
`Fax: 612-288-9696
`Email: PTABInbound@fr.com
`Matthew S. Colvin
`Reg. No. 66,843
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Phone: 202-783-5070
`Fax: 612-288-9696
`Email: PTABInbound@fr.com
`
`
`
`8
`
`
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`Kenneth W. Darby, Jr.
`Reg. No. 65,068
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Phone: 202-783-5070
`Fax: 612-288-9696
`Email: PTABInbound@fr.com
`
`Please address all correspondence to lead and backup counsel. Patent Owner
`
`
`
`
`consents to service by electronic mail at the following addresses:
`
`Sanofi.IPR.Service@weil.com and PTABInbound@fr.com.
`
`A power of attorney from Patent Owner was previously submitted.
`
`
`
`Date: June 11, 2019
`
`
`
` Respectfully submitted,
`
`/Elizabeth Stotland Weiswasser/
`Elizabeth Stotland Weiswasser
`Reg. No. 55,721
`Lead Counsel for Patent Owner
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`Phone: 212-310-8000
`
`
`
`9
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`The undersigned hereby certifies that on June 11, 2019, the foregoing
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES was served via
`
`electronic mail, upon the following:
`
`Richard Torczon
`Wesley Derryberry
`Tasha Thomas
`WILSON SONSINI GOODRICH & ROSATI
`1700 K Street NW, 5th Floor
`Washington, D.C. 20006
`rtorczon@wsgr.com
`wderryberry@wsgr.com
`tthomas@wsgr.com
`
`Douglas H. Carsten
`Jeffrey W. Guise
`Arthur Dykhuis
`WILSON SONSINI GOODRICH & ROSATI
`12235 El Camino Real, Suite 200
`San Diego, CA 92130
`dcarsten@wsgr.com
`jguise@wsgr.com
`adykhuis@wsgr.com
`
`Lorelei Westin
`WILSON SONSINI GOODRICH & ROSATI
`650 Page Mill Road
`Palo Alto, CA 94304
`lwestin@wsgr.com
`
`Franklin Chu
`WILSON SONSINI GOODRICH & ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`ychu@wsgr.com
`
`
`
`
`
`10
`
`
`
`Nicole W. Stafford
`WILSON SONSINI GOODRICH & ROSATI
`900 South Capital of Texas Highway
`Las Cimas, IV Fifth Floor
`Austin, TX 78746
`nstafford@wsgr.com
`
`Elham F. Steiner (Pro Hac Vice)
`WILSON SONSINI GOODRICH & ROSATI
`12235 El Camino Real,
`San Diego CA 92130
`esteiner@wsgr.com
`
`/Timothy J. Andersen/
`Timothy J. Andersen
`Case Manager
`Weil, Gotshal & Manges LLP
`2001 M Street, NW, Suite 600
`Washington, DC 20036
`timothy.andersen@weil.com
`
`11
`
`
`
`
`
`
`
`
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
